ARGENX SE is 38.2x more valuable than Monte Rosa Therapeutics, Inc. by market capitalization ($53.35 B vs $1.40 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GLUE | ARGX |
|---|---|---|
| Market cap | $1.40 B | $53.35 B |
| US-listed rank | #2377 | #306 |
| Net income (latest FY) | -$38.60M | - |
| SEC filings | 352 | 272 |
ARGENX SE is 38.2x more valuable than Monte Rosa Therapeutics, Inc. by market capitalization ($53.35 B vs $1.40 B).
Full pages: Monte Rosa Therapeutics, Inc. and ARGENX SE, or browse the full rankings.